Evaluation of blood gene expression levels in facioscapulohumeral muscular dystrophy patients

Facioscapulohumeral muscular dystrophy (FSHD) is caused by the expression of DUX4 in skeletal muscles. A number of therapeutic approaches are being developed to antagonize the events preceding and following DUX4 expression that leads to muscular dystrophy. Currently, the possibility to evaluate trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Signorelli, M., Mason, A. G., Mul, K., Evangelista, T., Mei, H., Voermans, N., Tapscott, S. J., Tsonaka, R., van Engelen, B. G. M., van der Maarel, S. M., Spitali, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567883/
https://www.ncbi.nlm.nih.gov/pubmed/33067535
http://dx.doi.org/10.1038/s41598-020-74687-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567883/
https://www.ncbi.nlm.nih.gov/pubmed/33067535
http://dx.doi.org/10.1038/s41598-020-74687-5

Ejemplares similares